Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Siddharth S Pujari

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Ophthalmology|December 18, 2013
Factors predictive of remission of new-onset anterior uveitisPichaporn Artornsombudh, Maxwell Pistilli, C Stephen Foster, et al.
Ophthalmology|December 9, 2009
Cyclophosphamide for ocular inflammatory diseasesSiddharth S Pujari, John H Kempen, Craig W Newcomb, et al.
Ophthalmology|July 17, 2012
Risk of hypotony in noninfectious uveitisEbenezer Daniel, Maxwell Pistilli, Siddharth S Pujari, et al.
American Journal of Ophthalmology|January 1, 2010
Mycophenolate mofetil for ocular inflammationEbenezer Daniel, Jennifer E Thorne, Craig W Newcomb, et al.
Ocular Immunology and Inflammation|March 14, 2012
High-dose intravenous corticosteroids for ocular inflammatory diseasesLeon D Charkoudian, Gui-shuang Ying, Siddharth S Pujari, et al.
American Journal of Ophthalmology|July 3, 2009
Azathioprine for ocular inflammatory diseasesSirichai Pasadhika, John H Kempen, Craig W Newcomb, et al.
American Journal of Ophthalmology|June 26, 2013
Risk of choroidal neovascularization among the uveitidesSally L Baxter, Maxwell Pistilli, Siddharth S Pujari, et al.
Ophthalmic Epidemiology|February 27, 2008
Methods for identifying long-term adverse effects of treatment in patients with eye diseases: the Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort StudyJohn H Kempen, Ebenezer Daniel, Sapna Gangaputra, et al.
Ophthalmology|December 22, 2015
Risk of Retinal Neovascularization in Cases of UveitisApurva K Patel, Craig W Newcomb, Teresa L Liesegang, et al.
Ophthalmology|January 15, 2020
Factors Predictive of Remission of Chronic Anterior UveitisLucia Sobrin, Maxwell Pistilli, Kurt Dreger, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Ophthalmology|December 18, 2013
Factors predictive of remission of new-onset anterior uveitisPichaporn Artornsombudh, Maxwell Pistilli, C Stephen Foster, et al.
Ophthalmology|December 9, 2009
Cyclophosphamide for ocular inflammatory diseasesSiddharth S Pujari, John H Kempen, Craig W Newcomb, et al.
Ophthalmology|July 17, 2012
Risk of hypotony in noninfectious uveitisEbenezer Daniel, Maxwell Pistilli, Siddharth S Pujari, et al.
American Journal of Ophthalmology|January 1, 2010
Mycophenolate mofetil for ocular inflammationEbenezer Daniel, Jennifer E Thorne, Craig W Newcomb, et al.
Ocular Immunology and Inflammation|March 14, 2012
High-dose intravenous corticosteroids for ocular inflammatory diseasesLeon D Charkoudian, Gui-shuang Ying, Siddharth S Pujari, et al.
American Journal of Ophthalmology|July 3, 2009
Azathioprine for ocular inflammatory diseasesSirichai Pasadhika, John H Kempen, Craig W Newcomb, et al.
American Journal of Ophthalmology|June 26, 2013
Risk of choroidal neovascularization among the uveitidesSally L Baxter, Maxwell Pistilli, Siddharth S Pujari, et al.
Ophthalmic Epidemiology|February 27, 2008
Methods for identifying long-term adverse effects of treatment in patients with eye diseases: the Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort StudyJohn H Kempen, Ebenezer Daniel, Sapna Gangaputra, et al.
Ophthalmology|December 22, 2015
Risk of Retinal Neovascularization in Cases of UveitisApurva K Patel, Craig W Newcomb, Teresa L Liesegang, et al.
Ophthalmology|January 15, 2020
Factors Predictive of Remission of Chronic Anterior UveitisLucia Sobrin, Maxwell Pistilli, Kurt Dreger, et al.
Pageof 2